What It Takes to Hit the 30-Day Turnaround: Optimizing the Manufacturing Workflow for mRNA Based PCVs to Deliver Rapid & Regulator-Ready Batches
Time: 11:00 am
day: Pre-Conference Manufacturing Focus Day
Details:
• Streamlining mRNA manufacturing workflows to reduce IVT, LNP, Purification cycle time, and manual intervention
• Optimizing Phase II manufacturing operations to support a smooth transition to latestage readiness with improved repeatability, regulatory alignment, and trial scalability
• Operationalizing real-time analytics, digital batch release, and platform-based regulatory strategies across end-to-end manufacturing